News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Margaret von Mehren, MD

Articles by Margaret von Mehren, MD

Margaret von Mehren, MD, chief of the Division of Sarcoma Medical Oncology, physician director of the Clinical Trials Office, associate director of Clinical Research, and professor of the Department of Hematology/Oncology at Fox Chase Cancer Center

Dr. von Mehren on Outcomes With Ribociclib/Everolimus in Dedifferentiated Liposarcoma

ByMargaret von Mehren, MD

June 12th 2021

Margaret von Mehren, MD, discusses outcomes with ribociclib and everolimus in dedifferentiated liposarcoma, as seen in the phase 2 SAR-096 trial.

Latest Updated Articles

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma

Oncology Fellows Presents a New Drug Cheat Sheet for Fellows

Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC